GIP

Q: Is GIP the same as glucagon?

No. GIP (gastric inhibitory polypeptide) is an incretin that enhances insulin secretion. Glucagon is a separate pancreatic hormone that raises blood glucose.

Q: Why is GIP important in tirzepatide research?

Tirzepatide is a dual GIP/GLP-1 receptor agonist. Understanding how GIP receptor activation contributes to metabolic effects requires studying GIP receptor pharmacology separately.

GIP

Glucose-Dependent Insulinotropic Polypeptide

Research Use Only · Not for Human Consumption

Glucose-dependent insulinotropic polypeptide (GIP), also known as gastric inhibitory polypeptide, is an incretin hormone secreted by K-cells in the duodenum and upper jejunum in response to fat and carbohydrate intake. GIP stimulates insulin secretion from beta cells, promotes fat storage in adipocytes, and has been shown to have effects on bone metabolism. The GIP receptor (GIPR) is targeted by tirzepatide alongside the GLP-1 receptor.

Key Facts

Secreted by: K-cells (duodenum/jejunum)
Receptors: GIPR (GIP receptor)
Role in fat metabolism: Promotes adipogenesis
Research interest: Dual/triple incretin agonists

Research Applications

Incretin physiology studies
Fat storage mechanism research
Bone metabolism studies
Dual GIP/GLP-1 receptor pharmacology
Obesity research models

Frequently Asked Questions

Is GIP the same as glucagon?

Why is GIP important in tirzepatide research?

Stock GIP on Your Research Compound Store

PeptiCommerce provides turn-key access to COA-documented research compounds. Your branded WooCommerce store with P2P and crypto payment support, ready in under 72 hours.

Get Started →

Key Facts

Research Applications

Frequently Asked Questions

Related Terms

Get the Research Peptide Business Playbook